HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
RAB39B
RAB39B, member RAS oncogene family
Chromosome X Β· Xq28
NCBI Gene: 116442Ensembl: ENSG00000155961.5HGNC: HGNC:16499UniProt: Q96DA2
59PubMed Papers
22Diseases
0Drugs
13Pathogenic Variants
FUNCTIONAL ROLE
Transporter
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
protein bindingvesicleneuron projectionGolgi apparatusearly-onset parkinsonism-intellectual disability syndromeEarly-onset parkinsonism - intellectual disabilityX-linked non-syndromic intellectual disabilitynon-syndromic X-linked intellectual disability
✦AI Summary

RAB39B is a small GTPase that regulates intracellular membrane trafficking and plays critical roles in neuronal function and homeostasis. As a member of the RAB family, RAB39B cycles between GDP-bound inactive and GTP-bound active forms to control vesicular transport processes 1. The protein is involved in multiple cellular pathways including autophagy regulation, where it controls trafficking of Atg9-positive vesicles from the soma to synapses, thereby regulating synaptic protein turnover 2. RAB39B also participates in glutamate receptor trafficking and Ξ±-synuclein homeostasis 3. Loss-of-function mutations in RAB39B cause X-linked intellectual disability and early-onset Parkinson's disease 14. In neurodegeneration, RAB39B dysfunction leads to impaired dopamine vesicular transmission and disrupted Ξ±-synuclein clearance, contributing to protein aggregation 4. Studies in dementia with Lewy bodies show RAB39B redistribution and sequestration within amyloid plaques and Lewy bodies, with reduced cytoplasmic availability that may facilitate pathological aggregation 5. The protein's role in PI3K-AKT-mTOR signaling also affects neural progenitor cell proliferation, linking its dysfunction to macrocephaly and autism spectrum disorders 1. These findings establish RAB39B as a crucial regulator of neuronal membrane trafficking with significant implications for neurodevelopmental and neurodegenerative diseases.

Sources cited
1
RAB39B regulates membrane trafficking, cycles between GDP/GTP-bound forms, and mutations cause X-linked neurodevelopmental defects and early-onset Parkinson's disease
PMID: 32761840
2
RAB39B controls trafficking of Atg9-positive vesicles and regulates synaptic autophagy and protein turnover
PMID: 40841711
3
RAB39B is involved in glutamate receptor trafficking and Ξ±-synuclein homeostasis
PMID: 33939203
4
RAB39B mutations impair dopamine vesicular transmission and Ξ±-synuclein clearance
PMID: 38444482
5
RAB39B is redistributed and sequestered in amyloid plaques and Lewy bodies in dementia with Lewy bodies
PMID: 32762091
Disease Associationsβ“˜22
early-onset parkinsonism-intellectual disability syndromeOpen Targets
0.78Strong
Early-onset parkinsonism - intellectual disabilityOpen Targets
0.75Strong
X-linked non-syndromic intellectual disabilityOpen Targets
0.70Moderate
non-syndromic X-linked intellectual disabilityOpen Targets
0.41Moderate
Parkinson diseaseOpen Targets
0.40Weak
Neurodevelopmental disorderOpen Targets
0.27Weak
developmental disorder of mental healthOpen Targets
0.27Weak
genetic disorderOpen Targets
0.18Weak
diffuse large B-cell lymphomaOpen Targets
0.08Suggestive
acute myeloid leukemiaOpen Targets
0.07Suggestive
Lewy body dementiaOpen Targets
0.06Suggestive
sleep apneaOpen Targets
0.05Suggestive
Sleep DisorderOpen Targets
0.04Suggestive
Alzheimer diseaseOpen Targets
0.04Suggestive
childhood disintegrative disorderOpen Targets
0.03Suggestive
Hashimoto's thyroiditisOpen Targets
0.03Suggestive
autismOpen Targets
0.02Suggestive
ParkinsonismOpen Targets
0.02Suggestive
osteosarcomaOpen Targets
0.02Suggestive
AnxietyOpen Targets
0.02Suggestive
Intellectual developmental disorder, X-linked 72UniProt
Waisman syndromeUniProt
Pathogenic Variants13
NM_171998.4(RAB39B):c.426TGC[1] (p.Ala144del)Likely pathogenic
Intellectual disability, X-linked 72
β˜…β˜†β˜†β˜†2024β†’ Residue 144
NM_171998.4(RAB39B):c.2T>C (p.Met1Thr)Pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 1
NM_171998.4(RAB39B):c.188G>A (p.Trp63Ter)Pathogenic
not provided
β˜…β˜†β˜†β˜†2022β†’ Residue 63
NM_171998.4(RAB39B):c.137dup (p.Ser47fs)Likely pathogenic
not provided|Intellectual disability, X-linked 72
β˜…β˜†β˜†β˜†2021β†’ Residue 47
NM_171998.4(RAB39B):c.559del (p.Glu187fs)Likely pathogenic
Developmental disorder
β˜…β˜†β˜†β˜†2021β†’ Residue 187
NM_171998.4(RAB39B):c.189G>T (p.Trp63Cys)Likely pathogenic
Neurodevelopmental disorder
β˜…β˜†β˜†β˜†2020β†’ Residue 63
NM_171998.4(RAB39B):c.559G>T (p.Glu187Ter)Pathogenic
Intellectual disability, X-linked 72
β˜…β˜†β˜†β˜†2016β†’ Residue 187
NM_171998.4(RAB39B):c.574G>A (p.Gly192Arg)Pathogenic
Parkinson disease, X-linked dominant|Early-onset parkinsonism-intellectual disability syndrome
β˜…β˜†β˜†β˜†2015β†’ Residue 192
NC_000023.11:g.(155246216_?)_(?_155288781)delPathogenic
Early-onset parkinsonism-intellectual disability syndrome
β˜…β˜†β˜†β˜†2014
NM_171998.4(RAB39B):c.503C>A (p.Thr168Lys)Pathogenic
Early-onset parkinsonism-intellectual disability syndrome|not provided
β˜…β˜†β˜†β˜†β†’ Residue 168
NC_000023.11:g.155264167_155265545delPathogenic
Early-onset parkinsonism-intellectual disability syndrome
β˜…β˜†β˜†β˜†
NM_171998.4(RAB39B):c.21C>A (p.Tyr7Ter)Pathogenic
Intellectual disability, X-linked 72
β˜†β˜†β˜†β˜†2010β†’ Residue 7
NM_171998.4(RAB39B):c.215+1G>APathogenic
Intellectual disability, X-linked 72
β˜†β˜†β˜†β˜†2010
View on ClinVar β†—
Related Genes
SMCR8Protein interaction100%C9orf72Protein interaction100%RAB8AProtein interaction97%WDR41Protein interaction97%SQSTM1Protein interaction94%GDI1Protein interaction66%
Tissue Expression6 tissues
Brain
100%
Bone Marrow
20%
Lung
3%
Heart
3%
Ovary
1%
Liver
1%
Gene Interaction Network
Click a node to explore
RAB39BSMCR8C9orf72RAB8AWDR41SQSTM1GDI1
PROTEIN STRUCTURE
Preparing viewer…
PDB6S5F Β· 1.70 Γ… Β· X-ray
View on RCSB β†—
RankingsWhere RAB39B stands among ~20K protein-coding genes
  • #7,807of 20,598
    Most Researched59
  • #2,606of 5,498
    Most Pathogenic Variants13
Genes detectedRAB39B
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
RAB39B's role in membrane traffic, autophagy, and associated neuropathology.
PMID: 32761840
J Cell Physiol Β· 2021
1.00
2
Dysfunction of RAB39B-Mediated Vesicular Trafficking in Lewy Body Diseases.
PMID: 33939203
Mov Disord Β· 2021
0.90
3
Expression of human Ras-related protein Rab39B variant T168K in
PMID: 38444482
Heliyon Β· 2024
0.80
4
RAB39B is redistributed in dementia with Lewy bodies and is sequestered within aΞ² plaques and Lewy bodies.
PMID: 32762091
Brain Pathol Β· 2021
0.70
5
Soma-localized Rab39 inhibits synaptic autophagy by controlling trafficking of Atg9 vesicles.
PMID: 40841711
EMBO J Β· 2025
0.60